Cargando…

HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco

BACKGROUND: HCV incidence is increasing in the US, notably among younger people who inject drugs (PWID). In a cohort of young adult (age<30 years) PWID in San Francisco we examined whether ‘injecting partner mixing’ factors, i.e. age of partner and knowledge of their HCV serostatus, were associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Page, Kimberly, Evans, Jennifer L., Hahn, Judith A., Vickerman, Peter, Shiboski, Stephen, Morris, Meghan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903751/ https://www.ncbi.nlm.nih.gov/pubmed/31821365 http://dx.doi.org/10.1371/journal.pone.0226166

Ejemplares similares

Intimate Injection Partnerships Are at Elevated Risk of High-Risk Injecting: A Multi-Level Longitudinal Study of HCV-Serodiscordant Injection Partnerships in San Francisco, CA
por: Morris, Meghan D., et al.
Publicado: (2014)

Impact of HCV Testing and Treatment on HCV Transmission Among Men Who Have Sex With Men and Who Inject Drugs in San Francisco: A Modelling Analysis
por: Artenie, Adelina, et al.
Publicado: (2023)

Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships
por: Hahn, Judith A, et al.
Publicado: (2019)

Housing Stability and Hepatitis C Infection for Young Adults Who Inject Drugs: Examining the Relationship of Consistent and Intermittent Housing Status on HCV Infection Risk
por: Morris, Meghan D., et al.
Publicado: (2020)

Per-Contact Infectivity of Hepatitis C Virus Acquisition in Association With Receptive Needle Sharing Exposures in a Prospective Cohort of Young Adult People who Inject Drugs in San Francisco, California
por: Leyva, Yuridia, et al.
Publicado: (2020)

Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California
por: Dias, Paulo Telles, et al.
Publicado: (2011)

HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California
por: Page, Kimberly, et al.
Publicado: (2017)

Injection partnership characteristics and HCV status associations with syringe and equipment sharing among people who inject drugs
por: Mackesy-Amiti, Mary Ellen, et al.
Publicado: (2023)

A cross‐sectional study comparing men who have sex with men and inject drugs and people who inject drugs who are men and have sex with men in San Francisco: Implications for HIV and hepatitis C virus prevention
por: Artenie, Adelina, et al.
Publicado: (2022)

It may take many villages, but progress can be made toward HCV elimination among people who inject drugs
por: Page, Kimberly
Publicado: (2023)

Modeling the role of incarceration in HCV transmission and prevention amongst people who inject drugs in rural Kentucky
por: Stone, Jack, et al.
Publicado: (2020)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

Progress toward closing gaps in the hepatitis C virus cascade of care for people who inject drugs in San Francisco
por: Mirzazadeh, Ali, et al.
Publicado: (2021)

HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England
por: Romo, Eric, et al.
Publicado: (2023)

Health and Oral Health Care Needs and Health Care-Seeking Behavior Among Homeless Injection Drug Users in San Francisco
por: Robbins, Jonathan Leserman, et al.
Publicado: (2010)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users
por: Huik, Kristi, et al.
Publicado: (2013)

A comparison of two biological markers of recent hepatitis C virus (HCV) infection: implications for the monitoring of interventions and strategies to reduce HCV transmission among people who inject drugs
por: Hope, Vivian D, et al.
Publicado: (2018)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
por: Degenhardt, Louisa, et al.
Publicado: (2017)

HCV and HIV co-infection among people who inject drugs in Vietnam
por: THINH, Vu Toan, et al.
Publicado: (2020)

Modelling the impact and cost‐effectiveness of non‐governmental organizations on HIV and HCV transmission among people who inject drugs in Ukraine
por: Stone, Jack, et al.
Publicado: (2023)

Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania
por: Fraser, Hannah, et al.
Publicado: (2021)

State HCV Incidence and Policies Related to HCV Preventive and Treatment Services for Persons Who Inject Drugs — United States, 2015–2016
por: Campbell, Cecily A., et al.
Publicado: (2017)

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
por: Martin, Natasha K, et al.
Publicado: (2013)

Barriers of linkage to HCV viremia testing among people who inject drugs in Georgia
por: Butsashvili, Maia, et al.
Publicado: (2022)

Molecular and spatial epidemiology of HCV among people who inject drugs in Boston, Massachusetts
por: Stopka, Thomas J., et al.
Publicado: (2022)

The signal-to-cutoff ratios to predict HCV infection among people who inject drugs
por: Chen, Bing, et al.
Publicado: (2022)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy
por: Martin, Natasha K., et al.
Publicado: (2013)

Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran
por: Mirzazadeh, Ali, et al.
Publicado: (2020)

Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam
por: Nguyen, Truong Tam, et al.
Publicado: (2018)

Hepatitis C virus care cascade among people who inject drugs in puerto rico: Minimal HCV treatment and substantial barriers to HCV care
por: Aponte-Meléndez, Yesenia, et al.
Publicado: (2023)

Gaps in HCV Knowledge and Risk Behaviors among Young Suburban People Who Inject Drugs
por: Jost, John J., et al.
Publicado: (2019)

Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India
por: Rodgers, Mary A., et al.
Publicado: (2020)

Reported Low Uptake of HCV Testing among People Who Inject Drugs in Urban Vietnam
por: Thinh, Vu Toan, et al.
Publicado: (2020)

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2021)

Spatial Analysis of HIV Positive Injection Drug Users in San Francisco, 1987 to 2005
por: Martinez, Alexis N., et al.
Publicado: (2014)

Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco
por: Carter, Jamie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_504tf8lft3ov9vi2gknthegn5f